The Application Value of Bronchoalveolar Lavage Fluid Metagenomic Next‐Generation Sequencing in Moderate‐to‐Severe Bronchiectasis
Journal of Clinical Laboratory Analysis · 2026
DOI: 10.1002/jcla.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2026. Verfasst von Jiachun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, Guangdong, China. Hauptthemen laut MEDLINE: Bronchiectasis, Bronchoalveolar Lavage Fluid, High-Throughput Nucleotide Sequencing, Metagenomics. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bronchiectasis, a leading chronic airway disease, often worsens due to infections, making rapid pathogen detection crucial. This study aims to evaluate the diagnostic value of bronchoalveolar lavage fluid (BALF) metagenomic next‐generation sequencing (mNGS) in identifying pathogens in moderate‐to‐severe bronchiectasis and compare its advantages to conventional methods.
Methods
Fifty‐two hospitalized patients initially diagnosed with moderate‐to‐severe bronchiectasis at Foshan Hospital of Traditional Chinese Medicine from May 2022 to March 2024 were enrolled. Clinical data and BALF samples were collected and subjected to both mNGS and conventional pathogen detection methods. The differences and concordance in pathogen distribution between mNGS and conventional methods, as well as their diagnostic performance, were compared.
Results
The positive detection rate of pathogens by mNGS was significantly higher than that by conventional methods ( p < 0.01). Both methods predominantly identified bacterial pathogens, with Pseudomonas aeruginosa being the most common bacterium and Aspergillus fumigatus the most frequent fungus. However, mNGS detected a broader range of pathogens and demonstrated superior sensitivity in identifying mixed infections ( p < 0.01). The sensitivity of mNGS was 66% higher than that of conventional methods ( p < 0.01), and the complete concordance rate between the two methods in double‐positive cases was 41.18%. Additionally, mNGS‐guided anti‐infection treatment significantly improves patient symptoms, reduces hospital stays, and lowers costs ( p < 0.05).
Conclusions
Compared with conventional methods, BALF mNGS demonstrates higher sensitivity, a greater positive detection rate, superior capability in identifying mixed infections, improved diagnostic performance, and a better guiding effect on anti‐infection treatment in moderate‐to‐severe bronchiectasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, Guangdong, China.
- Department of Respiratory Medicine, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong, China.
ORCID-Profile: Qiuping Quan
Zitieren
APA
Li, J., Quan, Q., Chen, J., Jian, X., Zhan, W., Wang, J., & Jiang, R. (2026). The Application Value of Bronchoalveolar Lavage Fluid Metagenomic Next‐Generation Sequencing in Moderate‐to‐Severe Bronchiectasis. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70156
Vancouver
Li J, Quan Q, Chen J, Jian X, Zhan W, Wang J, et al. The Application Value of Bronchoalveolar Lavage Fluid Metagenomic Next‐Generation Sequencing in Moderate‐to‐Severe Bronchiectasis. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70156
BibTeX
@article{Li2026,
author = {Li, Jiachun and Quan, Qiuping and Chen, Junshan and Jian, Xiaoyun and Zhan, Weijie and Wang, Jingmin and Jiang, Rongbin},
title = {The Application Value of Bronchoalveolar Lavage Fluid Metagenomic Next‐Generation Sequencing in Moderate‐to‐Severe Bronchiectasis},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
doi = {10.1002/jcla.70156}
}
EUVIMED